Criterios de derivación en incontinencia urinaria para atención primaria

Salinas Casado, 2010, Prevalencia de la incontinencia urinaria en España, URO A, 23, 52 Damián J, Brenes F, Pastor-Barriuso R, Salinas JI; en representación del Observatorio Nacional de la Incontinencia (ONI). Estimación de la prevalencia de incontinencia urinaria en España a partir de estudios publicados recientes. Póster presentado en el LXXIII Congreso Nacional de Urología. Barcelona, 13 al 16 de Junio de 2008. Kelleher, 2001, Quality of life and urinary incontinence, 47 Espuña Pons, 2003, Incontinencia de orina en la mujer, Med Clin (Barc), 120, 464, 10.1157/13045525 Hu, 1990, Impact of urinary incontinence on health-care costs, J Am Geriatr Soc, 38, 292, 10.1111/j.1532-5415.1990.tb03507.x Ekelund, 1993, Urinary incontinence. Social and financial costs high, BMJ, 306, 1344, 10.1136/bmj.306.6888.1344 Torre Lozano, 2002, Características de la población que precisa el uso de accesorios para la incontinencia urinaria en un centro de salud urbano, Medicina de Familia, 1, 15 Wallner, 2009, Prevalence and severity of undiagnosed urinary incontinence in women, Am J Med, 122, 1037, 10.1016/j.amjmed.2009.05.016 Ruiz Cerdá, 2007, Análisis de la adherencia de los urólogos españoles a las recomendaciones de diagnóstico y tratamiento de las guías de práctica clínica sobre incontinencia urinaria, Actas Urol Esp, 31, 1148, 10.1016/S0210-4806(07)73778-6 Páez Borda, 2007, Adecuación de las derivaciones desde atención primaria a un servicio de urología, Actas Urol Esp, 31, 1166, 10.1016/S0210-4806(07)73780-4 Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Oxford Centre for Evidence-based Medicine levels of evidence (March 2009) [consultado Jun 2012]. Centre for Evidence Based Medicine Web site. Disponible en: http://www.cebm.net/index.aspx?o=1025 Schröder A, Abrams P, Andersson KE, Último acceso: Junio 2012.et al. Guía clínica sobre la incontinencia urinaria. European Association of Urology 2010 [consultado Jun 2012]. Disponible en: http://www.aeu.es/UserFiles/11GUIA_CLINICA_SOBRE_LA_INCONTINENCIA_URINARIA.pdf Abizanda, 2002 Espuña, 2006, Incontinencia de orina, Med Clin (Barc), 7, 20 Mostwin J, Bourcier A, Haab F, Koebl S, Rao N, Resnick S, et al. Pathophysiology of urinary incontinence, fecal incontinence and pelvis organ prolapse. En: Abrams P, Cardozo L, Khoury S, Wein A, editores. Incontinence. Recommendations of International Scientific Committee. Basic evaluation. 3rd International Consultation on Incontinence. 2005. p. 423-484. Robles, 2006, Revisión: la incontinencia urinaria, Anales del Sistema Sanitario de Navarra, 29, 219, 10.4321/S1137-66272006000300006 Martin, 2006, Systematic review and evaluation of methods of assessing urinary incontinence, Health Technol Assess, 10, 1, 10.3310/hta10060 Lucas MG, Bosch RJL, Burkhard FC, Cruz F, Madden TB, Nambiar AK, et al. Guidelines on Urinary Incontinence 2012. EUA [consultado Jun 2012]. Disponible en: http://www.uroweb.org/gls/pdf/18_Urinary_Incontinence_LR.pdf Abrams, 2010, Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence, Neurourol Urodyn, 29, 213, 10.1002/nau.20870 Espuña, 2004, Validación de la versión española del International Consultation on Incontinente Questionnaire-Short Form. Un cuestionario para evaluar la incontinencia urinaria, Med Clin (Barc), 122, 288, 10.1016/S0025-7753(04)74212-8 Glazener CMA, Lapitan MC. Investigaciones urodinámicas para el tratamiento de la incontinencia urinaria en adultos (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008. Número 4. Oxford: Update Software Ltd. (traducida de The Cochrane Library, 2008 Issue 3. Chichester, UK: John Wiley & Sons, Ltd. [consultado Jun 2012]. Disponible en: http://www.update-software.com Abrams, 2002 Thüroff, 2011, EAU Guidelines on Urinary Incontinence, Actas Urol Esp, 35, 373, 10.4321/S0210-48062011000700001 National Institute for Health and Excellence. Urinary incontinence: the management of urinary incontinence in women. NICE clinical guideline 40 [consultado Jun 2012]. Disponible en: http://www.nice.org.uk/nicemedia/pdf/CG40NICEguideline.pdf Shamliyan T, Wyman J, Kane RL. Nonsurgical treatments for urinary incontinence in adult women: diagnosis and comparative effectiveness [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 [consultado Jun 2012]. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK92960/pdf/TOC.pdf Fader, 2008, Absorbent products for moderate-heavy urinary and/or faecal incontinence in women and men, Cochrane Database Syst Rev, CD007408 Schnelle, 2010, A controlled trial of an intervention to improve urinary and fecal incontinence and constipation, J Am Geriatr Soc, 58, 1504, 10.1111/j.1532-5415.2010.02978.x Hay-Smith, 2008, Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women, Cochrane Database Syst Rev, CD007471 Hay-Smith, 2011, Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women, Cochrane Database Syst Rev, CD009508 Dumoulin, 2011, Determining the optimal pelvic floor muscle training regimen for women with stress urinary incontinence, Neurourol Urodyn, 30, 746, 10.1002/nau.21104 Wallace, 2004, Bladder training for urinary incontinence in adults, Cochrane Database Syst Rev, CD001308 Andersson, 2005, Pharmacological treatment of urinary incontinence, 809 Nabi G, Cody JD, Ellis G, Hay-Smith J. Fármacos anticolinérgicos versus placebo para el síndrome de vejiga hiperactiva en adultos (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 4. Oxford: Update Software Ltd. (traducida de The Cochrane Library, 2008 Issue 3. Chichester, UK: John Wiley & Sons, Ltd.) [consultado Jun 2012]. Disponible en: http://www.update-software.com Chapple, 2008, The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis, Eur Urol, 54, 543, 10.1016/j.eururo.2008.06.047 Hay-Smith J, Herbison P, Ellis G, Morris A. Fármacos anticolinérgicos para el tratamiento sintomático de la vejiga hiperactiva en adultos (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008. Número 4. Oxford: Update Software Ltd. (Traducida de The Cochrane Library, 2008 Issue 3. Chichester, UK: John Wiley & Sons, Ltd.) [consultado Jun 2012]. Disponible en: http://www.update-software.com Madhuvrata, 2012, Which anticholinergic drug for overactive bladder symptoms in adults, Cochrane Database Syst Rev, 1, CD005429 Colli, 2007, Overactive bladder treatments in early phase clinical trials, Expert Opin Investig Drugs, 16, 999, 10.1517/13543784.16.7.999 Chapple, 2005, The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis, Eur Urol, 48, 5, 10.1016/j.eururo.2005.02.024 Roxburgh C, Cook J, Dublin N. Fármacos anticolinérgicos versus otros fármacos para el síndrome de vejiga hiperactiva en adultos (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008. Número 4. Oxford: Update Software Ltd. (traducida de The Cochrane Library, 2008. Issue 3. Chichester, UK: John Wiley & Sons, Ltd.) [consultado Jun 2012]. Disponible en: http://www.update-software.com Molero, 2010, Referral criteria for benign prostatic hyperplasia in primary care, Aten Primaria, 42, 36, 10.1016/j.aprim.2009.07.006 National Institute for Health and Clinical Excellence (NICE). Lower urinary tract symptoms: The management of lower urinary tract symptoms in men 2010 [consultado Jun 2012]. Disponible en: http://publications.nice.org.uk/lower-urinary-tract-symptoms-cg97/other-versions-of-this-guideline#full-guideline Chapple, 2011, Systematic review of therapy for men with overactive bladder, Can Urol Assoc J, 5, S143, 10.5489/cuaj.11186 Chapple, 2009, Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers, Eur Urol, 56, 534, 10.1016/j.eururo.2008.11.026 MacDiarmid, 2008, Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study, Mayo Clin Proc, 83, 1002, 10.4065/83.9.1002 Kaplan, 2006, Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial, JAMA, 296, 2319, 10.1001/jama.296.19.2319 Drake M, Chapple C, Van Kerrebroeck P, Drogendijk T, Klaver M. Efficacy of combination therapy with tamsulosin OCAS™ and solifenacin in NEPTUNE: Results from a randomised, phase 3 trial in men with LUTS. Presentado en 27th Annual EAU Congress. 24-28 Febrero 2012. París (Francia): P:AM12-2045. Cardozo, 2004, A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder, Acta Obstet Gynecol Scand, 83, 892, 10.1111/j.0001-6349.2004.00581.x DeLancey, 1990, Functional anatomy of the female lower urinary tract and pelvic floor, Ciba Found Symp, 151, 57 Delancey, 1994, Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis, Am J Obstet Gynecol, 170, 1713, 10.1016/S0002-9378(94)70346-9 Delancey, 2002, Fascial and muscular abnormalities in women with urethral hypermobility and anterior vaginal wall prolapse, Am J Obstet Gynecol, 187, 93, 10.1067/mob.2002.125733 Álvarez, 2010, Complicaciones de la cirugía de incontinencia urinaria femenina con minicintas, Actas Urol Esp, 34, 893, 10.1016/j.acuro.2010.04.007